Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury

Proceedings of the National Academy of Sciences of the United States of America

Volumn 91, Issue 20, 1994, Pages 9253-9256

  Eizirik, Décio L ^a   Pipeleers, Daniel G ^b   Ling, Zhidong ^b   Welsh, Nils ^a   Hellerström, Claes ^a   Andersson, Arne ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

alloxan; insulin dependent diabetes mellitus; nitric oxide; streptozotocin

Indexed keywords

ALLOXAN; GLUCOSE; NITROPRUSSIDE SODIUM; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DOSE RESPONSE; FLOW CYTOMETRY; GLUCOSE OXIDATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; TISSUE CULTURE;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 0028049833     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.91.20.9253     Document Type: Article

References (25)

1. Eisenbarth, G. S. (1986) N. Engl. J. Med. 314, 1360-1368.
2. Skyler, J. S. & Marks, J. B. (1993) Diabetes Rev. 1, 15-42.
3. Eizirik, D. L., Sandler, S. & Palmer, J. P. (1993) Diabetes 42, 1383-1391.
4. Mandrup-Poulsen, T., Helqvist, S., Wogensen, L. D., Mølvig, J., Pociot, F., Johannensen, J. & Nerup, J. (1990) Curr. Top. Microbiol. Immunol. 164, 169-193.
5. Sandler, S., Eizirik, D. L., Svensson, C., Strandell, E., Welsh, M. & Welsh, N. (1991) Autoimmunity 10, 241-253.
6. Rabinovitch, A. (1993) Diabetes Rev. 1, 215-240.
7. Corbett, J. A. & McDaniel, M. L. (1992) Diabetes 41, 897-903.
8. Kolb, H. & Kolb-Bachofen, V. (1992) Diabetologia 35, 796-797.
9. Eizirik, D. L., Sandler, S., Welsh, N., Cetkovic-Cvrlje, M., Nieman, A., Geller, D. A., Pipeleers, D. G., Bendtzen, K. & Hellerström, C. (1994) J. Clin. Invest. 93, 1968-1974.
10. Feelisch, M. & Noack, F. (1987) Eur. J. Pharmacol. 139, 19-30.
11. Wilson, G. L. & LeDoux, S. P. (1993) in Lessons from Animal Diabetes, ed. Shafrir, E. (Smith-Gordon, London), Vol. 4, pp. 17-26.
12. Malaisse, W. J. (1982) Biochem. Pharmacol. 31, 3527-3534.
13. Pipeleers, D. & Van de Winkel, M. (1986) Proc. Natl. Acad. Sci. USA 83, 5267-5271.
14. Eizirik, D. L., Korbutt, G. S. & Hellerström, C. (1992) J. Clin. Invest. 90, 1263-1268.
15. Pipeleers, D., in't Veld, P., Van de Winkel, M., Maes, E., Schuit, F. & Gepts, W. (1985) Endocrinology 117, 806-816.
16. Van De Winkel, M., Maes, E. & Pipeleers, D. (1982) Biochem. Biophys. Res. Commun. 107, 525-532.
17. Andersson, A. (1978) Diabetologia 14, 397-404.
18. Moreira, J. E., Hand, A. R., Borg, L. A. H., Sandler, S., Welsh, M., Welsh, N. & Eizirik, D. L. (1991) Virchows Arch. B 60, 337-344.
19. Eizirik, D. L., Sandler, S., Welsh, N. & Hellerström, C. (1988) Endocrinology 122, 1242-1249.
20. Eizirik, D. L. & Sandler, S. (1988) Pharmacol. Toxicol. 63, 396-399.
21. Mellgren, A., Schnell Landström, A. H., Petersson, B. & Andersson, A. (1986) Diabetologia 29, 670-672.
22. Weiss, R. B. (1982) Cancer Treat. Rep. 66, 427-438.
23. Tuch, B. E., Turtle, J. R. & Simeonovic, C. J. (1989) Diabetologia 32, 678-684.
24. Kato, H., Harada, M., Tsuchiya, K. & Moriwaki, K. (1980) Jpn. J. Genet. 55, 99-108.
25. Cleaver, J. E. (1994) Cell 76, 1-4.